Credent Connect N CareShare price, financial results, shareholding and management

NSE Emerge · CREDENTHealthcare logisticsListed 20 Aug 2026IPO ₹189Catch them young
Live price on NSE ↗ISIN INE1KPX01025 · Lot 600 shares · ₹2.34 lakh
₹389.80
-3.00% on the day
Close · 6 Nov 2026
Valuation
Market cap
₹710 cr
Stock P/E
39.5peers 6.9
Book value
₹24.1
Price to book
16.17
EV / operating profit
-
Market cap to sales
3.32
Returns and growth
ROCE · FY26
66.7%
ROE · FY26
69.6%
ROE, 3-year average
69.6%
Operating margin · FY26
13.0%peers 7.0%
Sales growth, 3 years
+260.8%
Profit growth, 3 years
+611.5%
Safety
Debt to equity
0.50peers 0.20
Borrowings
₹22 cr
Interest cover
26.0×
Cash from business / op. profit
-24%
Debtor days
100
Pledged
0.00%
Ownership and share
Promoter holding
63.75%
Change in promoter holding
-
Shareholders
1,894
High / low since listing
₹420 / ₹292
Dividend yield
0.00%
Face value
₹10

Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.

Credent Connect N Care share price chart

₹389.80+3.38% since listing

Close on 6 Nov 2026 · -2.96% on the day · Vol 38,400

Daily prices to 6 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.

Share price returns

To the close of 6 Nov 2026

1 month
+5.2%
Since IPO
+106.2%
Traded a day, 20 days
₹1.98 cr
Taken for delivery
78%

Business growth

Sales and net profit, from the reported results

SalesProfit
FY26 on FY23+261%+611%
3 years, a year--

About Credent Connect N Care: business, products and customers

Credent Connect N Care collects and carries blood samples, test kits and other medical goods for diagnostic labs, hospitals and drug companies, and supplies trained staff who work inside those labs and hospitals. Its shares trade on NSE Emerge.

Credent Connect N Care started in Delhi in 2015 with a small team of field staff. It now moves diagnostic samples from homes and collection centres to labs under temperature control, carries reagents from makers' depots to labs, and places phlebotomists, lab technicians and paramedical staff at client sites. It also runs health camps for companies under the C3 Wellness name and a courier booking platform called C3 Post.

Its customers are diagnostic lab chains, test kit makers, drug companies, hospitals and clinics. In FY26 healthcare services gave the largest share of sales, followed by logistics and stationed operations teams; Maharashtra and Uttar Pradesh were the two biggest states. The company owns a fleet of vehicles and works from rented warehouses and branch offices in Delhi, Mumbai, Pune, Chennai and Varanasi.

Read more about the business

What is new: during FY26 the company bought three companies, Credent Healthcare, Credent Team and Alltrak Technologies, from its promoters and its chief operating officer, and it says most of the jump in FY26 sales came from adding them. The shares listed on NSE Emerge in August 2026, and the offer document says most of the money raised is for working capital.

From the red herring prospectus (August 2026) and the FY26 annual report.

Read the deeper study ↓

In its favour

  • Sales have grown very fast: 261% a year last year.
  • It earns a high return on the money it uses: ROCE 67% in FY26.
  • The promoters own a large part of the company: 63.75%.

To watch

  • Spending of the issue money as planned across FY27 and FY28, including ₹26.8 cr for Credent Healthcare's working capital and ₹3.0 cr for its machinery (Red herring prospectus, p.91 and p.92).
  • Collection of the ₹58.8 cr owed by customers at March 2026, of which ₹8.7 cr was work not yet billed (Annual report FY26, p.112).
  • How the three subsidiaries bought in FY26 fit in, which the company itself names as a risk (Annual report FY26, p.14).
  • Whether the top ten customers, who gave 81.76% of FY26 sales without firm commitments, stay with the company (Red herring prospectus, p.25).
  • Customers take longer to pay than before: 100 days in FY26, against 62 in FY23.

From the company's documents first, then the reported figures read by fixed rules, the same for every company. Facts, not a view on the shares.

Credent Connect N Care revenue and profit growth

Half-yearly results · Profit and loss

Sales have grown very fast. Last year profit grew faster than sales, so the company kept more from each rupee of sales.

Sales and net profit, every year, ₹ crore
SalesNet profit
0100200300Sales, FY23: 59.3 ₹ cr59.3Net profit, FY23: 2.5 ₹ cr2.5FY23Sales, FY26: 214 ₹ cr214Net profit, FY26: 18 ₹ cr18FY26
The latest halves, ₹ crore
SalesNet profit
0255075100Sales, H1FY26: 90 ₹ cr90Net profit, H1FY26: 8 ₹ cr8H1FY26

SME companies report every six months.

Credent Connect N Care half-yearly results

SME companies report every six months · ₹ crore

₹ crore · growth on the same half a year before
H1FY26
Sales90
Expenses78
Operating profit12
OPM13.0%
Interest1
Depreciation1
Profit before tax10
Net profit8

Credent Connect N Care profit and loss

Full years to March, FY23 to FY26 · ₹ crore, consolidated where reported

₹ crore
FY23FY26
Sales59.32214
Expenses55.92185
Operating profit3.4029
OPM5.7%13.0%
Other income0.590
Interest0.381
Depreciation0.183
Profit before tax3.4325
Tax rate26.2%28.0%
Net profit2.5318
EPS ₹1,26513.92
Dividend payout0.0%0.0%

Earnings per share before FY26 is on the share count of that time, before later bonus or share issues, so it does not compare with the years after.

Credent Connect N Care profitability

Margins and returns on capital

Last year the company kept more from each rupee of sales than the year before. It earns a high return on the money it uses.

Operating margin, every year

Per cent of sales kept before interest, depreciation and tax

0%5%10%15%FY23: 5.7%5.7%FY23FY26: 13.0%13.0%FY26
Per cent
FY23FY26
Operating margin5.7%13.0%
Tax rate26.2%28.0%
ROCE·66.7%
ROE·69.6%
Dividend payout0.0%0.0%

Credent Connect N Care debt and cash flow

Balance sheet · Cash flow · Working capital

The company's own money, its net worth, has grown fast. It borrowed much more last year. Its loans are smaller than its own money. Last year the business used more cash than it brought in. It spent more on assets and investments than the business brought in, and raised the rest from loans or shares. Customers take longer to pay than they did in FY23, which ties up more of the company's money in unpaid bills.

Its own money and its borrowings, ₹ crore
Net worthBorrowings
0204060Net worth, FY23: 7.8 ₹ cr7.8Borrowings, FY23: 4.2 ₹ cr4.2FY23Net worth, FY26: 44 ₹ cr44Borrowings, FY26: 22 ₹ cr22FY26
Cash from the business against net profit, ₹ crore
Cash from the businessNet profit
-1001020Net profit, FY23: 2.5 ₹ cr2.5FY23Cash from the business, FY26: -7 ₹ cr-7Net profit, FY26: 18 ₹ cr18FY26

Bars below the line are cash going out.

Credent Connect N Care balance sheet

At each 31 March · ₹ crore

₹ crore
FY23FY26
Equity capital0.2013
Reserves7.5631
Net worth7.7644
Borrowings4.1622
Other liabilities3.4516
Total liabilities15.3782
Fixed assets2.2012
Capital work in progress03
Investments0.200
Other assets12.9767

Credent Connect N Care cash flow

₹ crore

₹ crore
FY23FY26
Cash from operations·-7
Cash from investing·-11
Cash from financing·19
Net cash flow·1

Working capital

Days

Days
FY23FY26
Debtor days62100
Inventory days·0
Cash conversion cycle62100
Working capital days4251

Credent Connect N Care peers and competitors

Listed SME companies in the same industry

By sales, Credent Connect N Care is number 17 of the 86 listed SME companies in commercial services & supplies.

Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.

CompanyMarket cap ₹ crP/ESales ₹ crProfit ₹ crOp. marginDebt/equity
ANI Integrated Services376.92545.43.4%0.20
PAN HR Solution374.723583.3%0.00
Credent Connect N Care71039.52141813.0%0.50
Service Care9418.719352.5%0.01
Sunrise Efficient Marketing555.5174107.0%-
Monarch Surveyors and Engineering Consultants3389.11723730.0%0.05
Diensten Tech99-163-2.85.5%2.95
NSB BPO Solutions725.51601312.0%0.05
Khyati Global Ventures335.514967.0%1.08
Qualitek Labs67044.71251524.0%0.61
Rockingdeals Circular Economy19519.71209.913.6%0.22
Median of the 10 others836.916797.0%0.20

Credent Connect N Care shareholding pattern

Promoters, FIIs, DIIs, HNIs and small holders

The promoters own more than half the company. Foreign and Indian funds own a noticeable share.

Promoters
63.75%
Foreign investors (FIIs)
3.06%
Indian institutions (DIIs)
9.23%
HNIs (over ₹2 lakh each)
6.26%
Small holders (up to ₹2 lakh)
12.37%
Companies and others
5.33%
Number of shareholders
1,894
1,894 in Aug 26

Credent Connect N Care shareholding pattern

Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.

Aug 26
Promoters63.75%
Foreign investors (FIIs)3.06%
Indian institutions (DIIs)9.23%
HNIs (over ₹2 lakh each)6.26%
Small holders (up to ₹2 lakh)12.37%
Companies and others5.33%
Number of shareholders1,894

The named holders are at 19 Aug 2026, each under the group the pattern files them in.

Credent Connect N Care study: the business from its own documents

Read from 3 of the company's own documents

Credent Connect N Care so far

From the company's own record

  1. June 2015Company formed
  2. 20 Aug 2026Listed on NSE Emerge at ₹189
  3. 31 Aug 2026Promoters at 63.75%
  4. 29 Sept 2026Highest close since listing, ₹407.45

Credent Connect N Care key facts from the filings

Each figure with the document it comes from

Labs served
2,530
Diagnostic labs linked to the company at March 2026, up from 1,675 two years earlier.Annual report FY26, p.11; Red herring prospectus, p.124
Top ten customers
81.76%
Share of FY26 sales from the ten largest customers, with no firm long-term commitments; the largest alone gave 15.76%.Red herring prospectus, p.25 and p.26
Workforce
6,338
People working for the group at March 2026, of whom 2,286 were on contract.Annual report FY26, p.18
Fleet and riders
97 vehicles
Commercial vehicles owned at June 2026, with 2,589 riders carrying samples on the last leg.Red herring prospectus, p.123; Annual report FY26, p.18
Healthcare services
₹92.2 cr
FY26 sales from healthcare services, the largest line at 43.04% of sales; logistics gave ₹54.1 cr.Annual report FY26, p.113
Show 5 more facts
Bought from insiders
₹11.5 cr
Price paid to Ashok Kumar Sharma and Dimple Sharma for Credent Healthcare; the other two companies came from Karan Sharma, Dimple Sharma, Tarun Sharma and Amit Gupta.Red herring prospectus, p.153
Money owed by customers
₹58.8 cr
Trade receivables at March 2026, up from ₹17.9 cr, including ₹8.7 cr of work done but not yet billed.Annual report FY26, p.112
Cash from operations
₹-6.6 cr
Cash went out of the business in FY26 even though the year showed a profit.Red herring prospectus, p.34
Second half weight
57.91%
Share of FY26 sales earned from October to March; the company says the second half is usually stronger.Red herring prospectus, p.30
Staff cost
39.46%
Employee costs as a share of FY26 total income, the biggest single cost.Red herring prospectus, p.234

What the company said, and what happened

The company's own statements, attributed, set against what it later reported; not newboard's estimates

The company has no order book; it bills clients each month for staff, sample runs and routes. The offer document sets out how the money raised in the August 2026 issue is to be spent across FY27 and FY28: working capital for the company and for its subsidiary Credent Healthcare, machinery for Credent Healthcare, and repayment of some loans. The company says it plans to add warehousing and long-distance healthcare logistics for existing clients and to reach smaller cities.

₹37.0 crWorking capital from the issueFY27 and FY28, offer document
₹26.8 crFor Credent Healthcare's working capitalFY27 and FY28, offer document
₹6.0 crLoan repaymentFY27, offer document

Is it a good business? Six questions

Each answer is about that one question, read from the documents; tap one for the evidence. Not a view on the shares.

Credent Connect N Care earns its money by sending people and vehicles to do sample collection and transport work for labs and hospitals, billed every month.

Its weak spots are a handful of large customers with no firm contracts, a lot of money tied up in unpaid bills, and a recent jump in size that came from buying companies owned by insiders.

WatchCan it set its own prices?Not much. Large lab chains can push for lower rates when contracts come up for renewal, while wages and fuel costs keep rising.
The evidence. The company says clients may seek price cuts, change the scope of work or reduce the number of vendors at renewal, and that its margins depend on managing wage inflation, fuel costs and vendor prices.Red herring prospectus, p.27; Annual report FY26, p.14
AverageHow strong is it against rivals?It has quality certificates, a wide network of labs and staff already placed inside clients, but the work itself is people and transport that rivals can also offer.
The evidence. Holds ISO 9001:2015 and ISO 15189:2022 certificates and served 2,530 labs at March 2026. The company says new or existing players offering similar services may bring pricing pressure, and that consolidation of lab chains raises the bar on scale.Red herring prospectus, p.123 and p.26; Annual report FY26, p.10
WatchWho are its customers?A few large customers give most of the sales, and none has signed a firm long-term commitment.
The evidence. Top ten customers gave 81.76% of FY26 sales and the largest 15.76%. The company says it has not lost any top ten customer in the last three years.Red herring prospectus, p.25 and p.26
WatchDoes it need a lot of money?It needs few factories, but a lot of cash is tied up in bills that clients have not yet paid, so growth eats working capital.
The evidence. Trade receivables were ₹58.8 cr at March 2026, including ₹8.7 cr not yet billed, and cash from operations was ₹-6.6 cr in FY26. Of the issue money, ₹37.0 cr and ₹26.8 cr are set aside for working capital in the company and Credent Healthcare.Annual report FY26, p.112; Red herring prospectus, p.34 and p.91
AverageCan it keep finding new work?Clients come back each month and the number of labs it works with keeps growing, but the biggest recent gain came from buying companies.
The evidence. Labs served rose from 1,675 in March 2024 to 2,530 in March 2026. The company says about 280 customers gave repeat business in FY26, 38 of them for three straight years, and that most of the FY26 rise in sales came from three acquired subsidiaries.Annual report FY26, p.11 and p.13; Red herring prospectus, p.126
AverageDo good and bad years swing a lot?Sales lean towards the second half of each year, and because staff and vehicle costs are fixed, a weak first half can hurt profit.
The evidence. In FY26, 57.91% of sales came from October to March. The company links this to health check-ups, wellness programmes and seasonal illness, and says many of its costs are fixed.Red herring prospectus, p.30

Who runs Credent Connect N Care?

Promoters, directors and officers; tap a name for the background

TSTarun SharmaPromoter, Chairman and Managing Director · holds 11.10%

Holds a Bachelor of Commerce (Honours) from Kalinga University, Raipur, with about 12 years of work in healthcare and diagnostic logistics, cold chain and paramedical services. Played a main part in setting up the business and looks after operations, finance, technology and quality. Chairman and Managing Director from 1 October 2025; FY26 pay of ₹24 lakh came from the subsidiary Alltrak Technologies.

Red herring prospectus, p.159, p.160 and p.162
KSKaran SharmaPromoter, Whole-Time Director and Chief Financial Officer · holds 12.34%

Holds an MBA from Sikkim Manipal University and has been with the company since 2018, with about nine years in healthcare supply chain, technology and tracking, and vendor management. Handles accounts, finance and administration. The prospectus states Karan Sharma is the brother of Tarun Sharma and a son of Ashok Kumar Sharma.

Red herring prospectus, p.159, p.160 and p.169
AKAshok Kumar SharmaPromoter and Non-Executive Director · holds 20.08%

Completed higher secondary education in 1978 and has more than 14 years of work in administration, day-to-day coordination and office documentation. On the board since September 2025. The prospectus states Ashok Kumar Sharma is the father of Tarun Sharma and Karan Sharma.

Red herring prospectus, p.159, p.160 and p.169
DSDimple SharmaPromoter and Non-Executive Director

Completed senior secondary education in 2003 and has 14 years of work in human resources and administration. On the board since September 2022 and a director of the subsidiaries Credent Healthcare and Credent Team. The prospectus states Dimple Sharma is the wife of Tarun Sharma.

Red herring prospectus, p.159, p.161 and p.169
TTanveenPromoter · holds 19.42%

Named a promoter in the prospectus, with over 14 years of experience in administration, budgeting and facility management. Not a director.

Red herring prospectus, p.171 and p.172
AGAmit GuptaChief Operating Officer

Appointed on 10 February 2026; an associate member of the Institution of Electronics and Telecommunication Engineers since 2001, with over 25 years in technology leadership, including software sold as a service and cloud systems. Earlier worked at Healthians, and was a seller of Alltrak Technologies to the company.

Red herring prospectus, p.153, p.168 and p.169
VYVanita YadavIndependent Director

Holds an M.Tech in electronics and communication engineering from Kurukshetra University, with about 29 years in education and skilling, quality systems and workforce programmes. On the board since September 2025.

Red herring prospectus, p.160 and p.161
TSTejpal SinghIndependent Director

Holds a doctorate from the Indian Agricultural Research Institute, New Delhi, with about 31 years in tax administration, customs and trade facilitation. On the board since December 2025 and chairs the audit committee.

Red herring prospectus, p.160, p.161 and p.164

Credent Connect N Care latest news and announcements

Announcements · Documents · Corporate actions

Credent Connect N Care annual reports, earnings calls and documents

Every document links to its source; “read” marks those this page is built from

Offer document
Annual reports

Credent Connect N Care share split, bonus and dividends

From the corporate actions the company announces on the exchange

No share split, bonus issue or dividend is on record since listing.

Checks we ran on Credent Connect N Care's data · 7

Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.

  • ✓Balance sheet totals add up for FY23 and FY26.
  • ✓Market cap uses the share count in the latest shareholding pattern (1,82,22,900 shares).
  • !The FY26 results imply 1,30,00,000 shares at face value ₹10, which disagrees with the shareholding pattern; the pattern is used.
  • ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
  • !Earnings per share changes basis between FY23 (₹1,265.00) and FY26 (₹13.92) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
  • ✓Revenue and profit are reported for every year shown, FY23 to FY26.
  • iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.

Questions people ask about Credent Connect N Care

What does Credent Connect N Care do?

Credent Connect N Care collects and carries blood samples, test kits and other medical goods for diagnostic labs, hospitals and drug companies, and supplies trained staff who work inside those labs and hospitals. Its shares trade on NSE Emerge.

What is the share price of Credent Connect N Care?

₹390 at the close on 6 Nov 2026, from the exchange's daily figures.

What is the market cap of Credent Connect N Care?

₹710 cr at the close on 6 Nov 2026, on 1,82,22,900 shares.

What is the P/E of Credent Connect N Care?

39.5 times FY26 profit at the close on 6 Nov 2026 (our arithmetic).

What are Credent Connect N Care's revenue and profit?

Revenue ₹214 cr and profit after tax ₹18 cr in FY26.

Who are the promoters of Credent Connect N Care?

Tarun Sharma, Karan Sharma, Ashok Kumar Sharma, Dimple Sharma, Tanveen; promoters held 63.75% at 31 Aug 2026.

What was the IPO price of Credent Connect N Care?

₹189 a share; it listed on 20 Aug 2026.

More SME companies like Credent Connect N Care

Other listed SME companies in commercial services & supplies, the closest in size first, each read from its own documents.

Every listed SME company in Commercial Services & Supplies → · SME companies listed in 2026 →

Built from 2 annual reports, 1 offer document, 11 exchange announcements, 1 shareholding patterns and 2 years of reported results. Every figure carries its source; where the documents are silent, the page says so.